News
Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...
Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over ...
AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia ...
IHH's Singapore-based indirect subsidiary Northern TK Ventures (NTK) has approached the Tokyo District Court seeking to amend ...
The lawsuit pertains to damages arising from the alleged obstruction by Daiichi of NTK’s efforts to acquire shares in Fortis ...
Explore more
Malaysia's IHH Healthcare has significantly increased its damage claim against Japan's Daiichi Sankyo in Tokyo District Court ...
IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...
IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...
1d
Clinical Trials Arena on MSNDaiichi Sankyo and MSD announce first subject dosing in oesophageal cancer trial"Daiichi Sankyo and MSD announce first subject dosing in oesophageal cancer trial" was originally created and published by ...
Tess Stynes - profile from The Wall Street Journal. News, articles, biography and photos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results